Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
2017
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Bioprinting exosome-like extracellular vesicle microenvironments
2019
Current knowledge on exosome biogenesis and release
2017 Standout
Functional diversity of helper T lymphocytes
1996 StandoutNature
Engineering precision nanoparticles for drug delivery
2020 Standout
Recombinant interferon‐ γ inhibits the growth of IL‐6‐dependent human multiple myeloma cell lines in vitro
1991
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cells
1993
Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma
1996
The biology of human natural killer-cell subsets
2001 Standout
HLA-A11-mediated protection from NK cell-mediated lysis
1996
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Extracellular vesicles mediate signaling between the aqueous humor producing and draining cells in the ocular system
2017
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc–dependent pathway
2001
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Redox regulation of immunometabolism
2020
Regulation of human cytolytic lymphocyte responses by interleukin-12
1992
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase
1999 StandoutNobel
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Juvenile idiopathic arthritis
2007 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity
2006
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice
2017
Hepatocellular carcinoma
2021 Standout
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
2003
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival
1997
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Optimization of cell culture conditions for exosome isolation using mini-size exclusion chromatography (mini-SEC)
2019
Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists
1995
Dendritic Cells as Immunogens for Human CTL Responses
1997 StandoutNobel
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Translocations involving anaplastic lymphoma kinase (ALK)
2001
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
2010 StandoutNobel
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
1998 StandoutNature
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Deciphering CD30 ligand biology and its role in humoral immunity
2006
The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat‐shock protein 60 capable of producing the regulatory cytokine interleukin‐10
2003
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Tumor necrosis factor signaling
2003 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial
2002 Standout
Programmed Cell Death as a Mechanism of CD4 and CD8 T Cell Deletion in AIDS: Molecular Control and Effect of Highly Active Anti‐retroviral Therapy
1999 StandoutNobel
The immunology of hepatocellular carcinoma
2018
Driving CAR T-cells forward
2016
Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB Activation
1997
Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression
1999
CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing Proteins
1996
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice
1996
NF-κB at the crossroads of life and death
2002 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor
1998 StandoutNobel
Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
1994
NK CELL RECOGNITION
2004 Standout
Remote control of therapeutic T cells through a small molecule–gated chimeric receptor
2015 Science
Exosomes
2019 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Induction of Nuclear Factor κB by the CD30 Receptor Is Mediated by TRAF1 and TRAF2
1997
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Nitric oxide and the immune response
2001 Standout
Routes and mechanisms of extracellular vesicle uptake
2014 Standout
Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
2017
Coccidioidomycosis: Host Response and Vaccine Development
2004
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Myeloid dendritic cells
1999 StandoutNobel
The biology and function of exosomes in cancer
2016
CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
1996
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
1998 Standout
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
2016
Aspergillus fumigatusand Aspergillosis
1999 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
1995
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Targeting Tumor Microenvironment for Cancer Therapy
2019
Exosome Biochemistry and Advanced Nanotechnology for Next‐Generation Theranostic Platforms
2018
Mechanogenetics for the remote and noninvasive control of cancer immunotherapy
2018
The Induction of Nitric Oxide by Interleukin-12 and Tumor Necrosis Factor- in Human Natural Killer Cells: Relationship With the Regulation of Lytic Activity
1998
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
1996
The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System
2000 Standout
CD30 and type 2 T helper (Th2) responses
1995
Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers
2019
Biology and clinical relevance of human natural killer cells
1990
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Creatine and Creatinine Metabolism
2000 Standout
Works of Patricia Simms being referenced
Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death
2016
Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets
2016
Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia
2017
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
2016
FOXO3–NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function
2015
Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms
2017
Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation
1996
Characterization of Uptake and Internalization of Exosomes by Bladder Cancer Cells
2014
CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.
1993
Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
1989